Oct 18 2010
Endotronix has been funded by an economic development group JumpStart Ventures to the tune of $250,000. Endotronix was founded by Harry Rowland, an engineer whose field of expertise is nanotechnology manufacturing, and a cardiothoracic surgeon, Dr. Anthony Nunez, in Peoria, Illinois, in the year 2007.
The company received two patent licenses from NASA Glenn Research Center in 2008, for developing wireless heart sensor technological devices.
The sensor once it is fixed inside the body, wirelessly sends out all the data to a portable device that in turn transmits the information to a remote station. It permits patients with congestive heart failure to remotely monitor their blood pressure readings. Later Endotronix opened another office in Cleveland after receiving a grant from Lorain County Community College Foundation Innovation Fund and also help from BioEnterprise Corp., an economic development group.
When the heart is not able to pump sufficient blood to manage the body’s needs, CHF or Congestive Heart Failure occurs. CHF mainly occurs because of high blood pressure or narrowed arteries. According to the National Heart Lung and Blood Institute, around 5.7 million people are suffering from heart failure in the U.S., leading to 300,000 deaths every year. Endotronix expects that this device would assist both doctors and the patients alike, in monitoring and treating heart failure reducing the need for hospitalization.